» Articles » PMID: 36852144

Comparisons of Pathologic Findings and Outcomes of Gastric Cancer Patients Younger and Older Than 40: a Propensity Score Matching Study in a Single Center of Korea

Overview
Journal JGH Open
Specialty Gastroenterology
Date 2023 Feb 28
PMID 36852144
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Gastric cancer (GC) is one of the most common cancers worldwide, with a high incidence rate in Korean men. However, comparative studies are scarce on the pathologic findings and treatment effects of GC in patients aged less than 40 years. We evaluated the characteristics and pathologic findings of GC patients aged younger and older than 40 years.

Methods: We retrospectively analyzed 2307 patients diagnosed with GC between January 2010 and May 2018. Eighty-eight (3.8%) and 2219 (96.2%) patients were younger and older than 40 years, respectively. The patients were divided into younger ( = 70) and older ( = 62) age groups through propensity matching.

Results: Overall, compared to the younger group, the older group ( = 2219) had a significantly higher proportion of male patients (66.7% 39.8%;  < 0.001) and patients who underwent endoscopic submucosal dissection (ESD) (2.3% 23.1%;  < 0.001). However, young patients more often underwent operations compared to older patients (78.4% 60.1%;  = 0.001). In the propensity-matched group, older patients more often showed differentiated carcinoma, including well-differentiated (5.7% 11.3%) and moderately differentiated (1.4% 32.3%). However, younger patients more often showed signet ring cell carcinoma (SRC) (70.0% 25.8%). In multivariate analysis, infection (odds ratio, 12.643; 95% confidence interval, 1.068-1449.665;  = 0.044) independently correlated with SRC risk.

Conclusions: Patients below 40 years were more likely to undergo surgery compared to ESD, and pathologic findings were more common in SRC. Therefore, more active screening and eradication are needed even in patients aged less than 40 years.

References
1.
. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

2.
Ji X, Bu Z, Yan Y, Li Z, Wu A, Zhang L . The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients. Gastric Cancer. 2017; 21(4):643-652. PMC: 6002446. DOI: 10.1007/s10120-017-0779-5. View

3.
Kim K, Kim Y, Kim M, Jung G . Analysis of prognostic factors and outcomes of gastric cancer in younger patients: a case control study using propensity score methods. World J Gastroenterol. 2014; 20(12):3369-75. PMC: 3964409. DOI: 10.3748/wjg.v20.i12.3369. View

4.
Kim S, Choi C . Common Locations of Gastric Cancer: Review of Research from the Endoscopic Submucosal Dissection Era. J Korean Med Sci. 2019; 34(35):e231. PMC: 6732260. DOI: 10.3346/jkms.2019.34.e231. View

5.
Kim Y, Kim Y, Choi I, Kim C, Lee J, Cho S . Long-term survival after endoscopic resection versus surgery in early gastric cancers. Endoscopy. 2015; 47(4):293-301. DOI: 10.1055/s-0034-1391284. View